Article Information
History
- June 4, 2021.
Article Versions
- Version 1 (October 2, 2020 - 12:12).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Eugene J. Gardner1,*,a,
- Alejandro Sifrim2,*,
- Sarah J. Lindsay1,
- Elena Prigmore1,
- Diana Rajan1,
- Petr Danecek1,
- Giuseppe Gallone1,
- Ruth Y. Eberhardt1,
- Hilary C. Martin1,
- Caroline F. Wright3,
- David R. FitzPatrick3,
- Helen V. Firth1,4 and
- Matthew E. Hurles1,b
- 1Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, Hinxton, CB10 1SA, United Kingdom
- 2Department of Human Genetics, KU Leuven, Herestraat 49, Box 602, Leuven, Belgium, B-3000
- 3University of Exeter Medical School, Institute of Biomedical and Clinical Science, Royal Devon & Exeter Hospital, Exeter, EX2 5DW, United Kingdom
- 4MRC Human Genetics Unit, University of Edinburgh, WGH, Edinburgh, EH4 2SP, United Kingdom
- 5East Anglian Medical Genetics Service, Box 134, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge CB2 0QQ, United Kingdom
- ↵bTo whom correspondence should be addressed: meh{at}sanger.ac.uk, +44 (0)1223 495377
↵* Contributed equally
Posted June 04, 2021.
Detecting cryptic clinically-relevant structural variation in exome sequencing data increases diagnostic yield for developmental disorders
